In the present study, we determine the contribution of IL-9 to Aspergillus infection and allergy in murine and human CF, and assess the therapeutic effectiveness of targeting IL-9-dependent pathways and the diagnostic potential of this approach. This evidence concerns the gene IL9 and allergic disease.